Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
CEO, Manny Villafana and Medical 21 are developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
McGinley Orthopedics have developed the IntelliSense Drill, an innovative handheld robotic technology which can change the standard of care in orthopedic procedures.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits.
Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).
Altoida is using technology to predict the onset of neurological diseases, such as Alzheimer's disease, before symptoms occur. The company's platform evaluates an individual's risk by interrogating 800 digital biomarkers collected through a digital assessment and augmented reality (AR).
Neurovine's platform consists of a wearable headband that utilizes electroencephalogram (EEG) and machine learning to provide patients with real-time reports on brain health.
Proxima works with emerging medical device companies across all phases of development. As a contract research organization, they organize their team in these distinct areas: regulatory and quality consulting and all-inclusive clinical trial services.
President & CEO, Todd Usen of Activ Surgical are utilizing AI, near-infrared fluorescent imaging, and robotics to enhance surgical visualition and navigation beyond what is visible from traditional imaging systems (e.g. endoscopy).
Rapid Nexus Nanotech Wound Solutions is an innovative wound company whose technology is based on nanomaterials and targets the electromagnetic cell division cycles (anaphase through telophase) to accelerate growth of tissue.
AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).
What are Strategics looking for, right now, and what's the best way (and when) to access them.
Paul Russo, Chairman & CEO of Kyto Technology & Life Science, was a presenter at the LSI Europe ‘22 Emerging Medtech Summit. KYTO is a Silicon Valley-based investment company focused on creating an ETF-like vehicle of diversified and thoroughly vetted start-ups thus defining an entirely new non-correlated asset class.
ECLEVAR supports medical devices and IVD manufacturer in the MDR and IVDR transition. Their team works as an extension team of medical affairs and regulatory affairs sponsor.
Bloomlife is a women’s health company solving the most significant yet underserved global challenges today in maternal health.
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night.
AccurECG is cloud-based web application that is compatible with holter monitors and consumer wearables that collects and analyzes ECG data in real-time using artificial intelligence.
Founder & CSO, Amos Ziv and CardiaCare are developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation.
CEO, Jorge Presa and Cyber Surgery are developing a high precision surgical robot for spinal surgery.
CEO, Richard Ljuhar and ImageBiopsy Lab are developing a portfolio of radiographic image analysis software solutions that utilize artificial intelligence to turn data into diagnostic evidence.
CEO, Lothar Krinke and Newronika are developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease.
CFO & COO, Jonathan Balfour and Panaxium aim to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.
Medtech Pro provides trusted data and insights in an intuitive software platform to improve decision-making for everyone, from startups and strategics to investors and insiders.
CEO, Peter Kassel and HealthySole are the pioneer and technology leader in reducing the pathogen load in settings where pristine environments are required.
CEO & Co-Founder, Pierre-Francois Migeotte and HeartKinetics are combining seismocardiography and ballistocardiography techniques to remotely measure cardiac vital signs.
CEO, Ruben de Francisco and Onera Health are developing diagnostic and monitoring solutions to help people with sleep-related ailments.
CEO, Piotr Wygocki and MIM Solutions are using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries.
CEO, Mike Karim and Oxford Endovascular are developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms
CEO, Brian Thornes and X-Bolt Trauma Therapeutics are developing next-generation devices for use during trauma surgeries. Key to the company's portfolio of orthopedic products are its expanding bolt design and the ability to easily reverse and remove implanted devices.
Locate Bio's orthobiologic products leverage Locate Bio's expertise in programmed drug release and instructive tissue scaffolds to enhance the tissue repair process.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms.
